Hsbc Holdings PLC Tiziana Life Sciences LTD Transaction History
Hsbc Holdings PLC
- $161 Billion
- Q2 2025
A detailed history of Hsbc Holdings PLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Hsbc Holdings PLC holds 105,365 shares of TLSA stock, worth $202,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105,365
Previous 105,365
-0.0%
Holding current value
$202,300
Previous $113,000
46.9%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TLSA
# of Institutions
35Shares Held
4.64MCall Options Held
0Put Options Held
0-
Dauntless Investment Group, LLC Commerce Township, MI3.42MShares$6.56 Million9.57% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il199KShares$382,0600.0% of portfolio
-
Zhang Financial LLC89.8KShares$172,3390.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA86.1KShares$165,2830.0% of portfolio
-
Hrt Financial LP New York, NY84.1KShares$161,4830.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $196M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...